Medicaid hepatitis C patients more likely to be denied drug coverage

Almost half of hepatitis C patients whose doctors had prescribed antiviral drugs were denied coverage to the therapies by Medicaid because they weren't considered "a medical necessity" or because the patients tested positive for alcohol/drugs, according to a study by University of Pennsylvania researchers.

The findings are in line with a previous study, which suggested that a lack of insurance is the "only barrier" facing those unable to obtain treatment for the disease. 

Additionally, the Penn study revealed that people with hepatitis C who sought prescriptions were significantly more likely to get turned down if they had Medicaid coverage than if they were insured by Medicare or private commercial policies. Study announcement



Suggested Articles

An estimated 73 million Americans with commercial health insurance face limited choices, according to a new American Medical Association study.

Absent adequate reimbursement for time spent on complex patient care, specialists are finding it harder to sustain their practices.

Tennessee released its proposal to CMS to become the first state to convert federal Medicaid funding into a block grant.